相似文献
1
Treatment Options for HIV-Associated Tuberculosis.
J Infect Dis. 2007 Aug 15;196 Suppl 1(Suppl 1):S35-45. doi: 10.1086/518657.
2
Timing of antiretroviral therapy for HIV in the setting of TB treatment.
Clin Dev Immunol. 2011;2011:103917. doi: 10.1155/2011/103917. Epub 2010 Dec 27.
3
4
National scale-up of tuberculosis-human immunodeficiency virus collaborative activities in Myanmar from 2005 to 2016 and tuberculosis treatment outcomes for patients with human immunodeficiency virus-positive tuberculosis in the Mandalay Region in 2015.
Trans R Soc Trop Med Hyg. 2017 Sep 1;111(9):402-409. doi: 10.1093/trstmh/trx073.
5
Adverse events during treatment of drug-resistant tuberculosis: a comparison between patients with or without human immunodeficiency virus co-infection.
Drug Saf. 2013 Nov;36(11):1087-96. doi: 10.1007/s40264-013-0091-1.
6
HIV infection-related tuberculosis: clinical manifestations and treatment.
Clin Infect Dis. 2010 May 15;50 Suppl 3:S223-30. doi: 10.1086/651495.
7
Management of individuals requiring antiretroviral therapy and TB treatment.
Curr Opin HIV AIDS. 2010 Jan;5(1):61-9. doi: 10.1097/COH.0b013e3283339309.
8
Tuberculosis and HIV co-infection: a practical therapeutic approach.
Drugs. 2006;66(18):2299-308. doi: 10.2165/00003495-200666180-00003.
9
Paradoxical reaction in HIV and tuberculosis coinfection.
J Assoc Physicians India. 2002 Apr;50:588-9.
10
Highly active antiretroviral therapy for patients with tuberculosis: the solution or the problem?
AIDS. 2002 Jul 5;16(10):1436-7. doi: 10.1097/00002030-200207050-00023.
引用本文的文献
1
Recent advancements in tuberculosis (TB) treatment regimens.
J Family Med Prim Care. 2025 Feb;14(2):521-525. doi: 10.4103/jfmpc.jfmpc_1237_24. Epub 2025 Feb 21.
2
Role of therapeutic drug monitoring in the treatment of multi-drug resistant tuberculosis.
J Clin Tuberc Other Mycobact Dis. 2024 Apr 24;36:100444. doi: 10.1016/j.jctube.2024.100444. eCollection 2024 Aug.
3
Pregnancy in a patient with endometrial tuberculosis by in vitro fertilization: a case report.
J Int Med Res. 2020 Nov;48(11):300060520967824. doi: 10.1177/0300060520967824.
4
The impact of alcohol use on tuberculosis treatment outcomes: a systematic review and meta-analysis.
Int J Tuberc Lung Dis. 2020 Jan 1;24(1):73-82. doi: 10.5588/ijtld.19.0080.
5
Profile and treatment outcomes of patients with tuberculosis in Northeastern Ethiopia: a cross sectional study.
Afr Health Sci. 2016 Sep;16(3):663-670. doi: 10.4314/ahs.v16i3.4.
6
Ovarian tuberculosis masquerading as ovarian cancer in HIV infected patient: a plea to avoid unnecessary surgery.
Pan Afr Med J. 2014 Oct 27;19:210. doi: 10.11604/pamj.2014.19.210.5072. eCollection 2014.
7
Experience with rifabutin replacing rifampin in the treatment of tuberculosis.
Int J Tuberc Lung Dis. 2011 Nov;15(11):1485-9, i. doi: 10.5588/ijtld.11.0068.
8
Tuberculosis and HIV co-infection: screening and treatment strategies.
Drugs. 2011 Jun 18;71(9):1133-52. doi: 10.2165/11591360-000000000-00000.
9
Validating five questions of antiretroviral nonadherence in a public-sector treatment program in rural South Africa.
AIDS Patient Care STDS. 2011 Mar;25(3):163-70. doi: 10.1089/apc.2010.0257. Epub 2011 Jan 26.
10
Initiating antiretrovirals during tuberculosis treatment: a drug safety review.
Expert Opin Drug Saf. 2011 Jul;10(4):559-74. doi: 10.1517/14740338.2011.546783. Epub 2011 Jan 5.
本文引用的文献
1
Complications of antiretroviral therapy in patients with tuberculosis: drug interactions, toxicity, and immune reconstitution inflammatory syndrome.
J Infect Dis. 2007 Aug 15;196 Suppl 1:S63-75. doi: 10.1086/518655.
2
Treatment strategies for HIV-infected patients with tuberculosis: ongoing and planned clinical trials.
J Infect Dis. 2007 Aug 15;196 Suppl 1:S46-51. doi: 10.1086/518658.
3
Implementation issues in tuberculosis/HIV program collaboration and integration: 3 case studies.
J Infect Dis. 2007 Aug 15;196 Suppl 1:S114-23. doi: 10.1086/518664.
4
Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: impact on treatment outcomes and implications for tuberculosis control.
AIDS. 2006 Aug 1;20(12):1605-12. doi: 10.1097/01.aids.0000238406.93249.cd.
5
Moxifloxacin versus ethambutol in the first 2 months of treatment for pulmonary tuberculosis.
Am J Respir Crit Care Med. 2006 Aug 1;174(3):331-8. doi: 10.1164/rccm.200603-360OC. Epub 2006 May 4.
6
Comparison of intermittent ethambutol with rifampicin-based regimens in HIV-infected adults with PTB, Kampala.
Int J Tuberc Lung Dis. 2006 Jan;10(1):39-44.
7
Exploring the determinants of treatment success for tuberculosis cases in Europe.
Int J Tuberc Lung Dis. 2005 Nov;9(11):1224-9.
8
Treatment of tuberculosis: present status and future prospects.
Bull World Health Organ. 2005 Nov;83(11):857-65. Epub 2005 Nov 10.
9
Micronutrient supplementation in children and adults with HIV infection.
Cochrane Database Syst Rev. 2005 Oct 19(4):CD003650. doi: 10.1002/14651858.CD003650.pub2.
10
Evaluation of the drug interaction between rifabutin and efavirenz in patients with HIV infection and tuberculosis.
Clin Infect Dis. 2005 Nov 1;41(9):1343-9. doi: 10.1086/496980. Epub 2005 Sep 29.
Zotero 插件